Statistical risk-based quality management software

Data as of Oct 7, 2026A topic in Clinical Trial Operations Platforms.Reviewed by Dimitry Apollonsky

How we measure

Which brands AI mentions

#BrandHow often mentioned

1CluePointsMost answers

2eClinical SolutionsRarely

3Good Statistical MonitoringRarely

4MedidataRarely

5Clinical Trial Anomaly SpotterRarely

See 8 more brands

Recommendations by AI engine

Mentioned in · Jul 5 – Oct 7, 2026

CluePointsChatGPT Search58%Google AI Mode96%
eClinical SolutionsChatGPT Search17%Google AI Mode52%
Good Statistical MonitoringChatGPT Search38%Google AI Mode9%
MedidataChatGPT Search8%Google AI Mode30%
Clinical Trial Anomaly SpotterChatGPT Search8%Google AI Mode0%

Questions and answers

How do we monitor risk? What "Risk-Based Quality Management" (RBQM) tool uses statistics to find data anomalies across sites?
ChatGPT SearchOct 7, 2026
1CluePoints
2Good Statistical Monitoring
In Risk-Based Quality Management (RBQM) for clinical trials, the tool/process that uses statistics to find unusual data patterns across sites is generally called Central Statistical Monitoring (CSM) or Statistical Data Monitoring (SDM).

What it does: statistically compares clinical-trial data across sites to identify outliers, anomalies, and systemic patterns that may indicate data-quality or operational risks.

How it works: statistical tests can generate site-level signals—for example, unusually low/high rates, variability, missing data, protocol deviations, or other measures. Some implementations use p-values and aggregate them into a site-level risk/data-inconsistency score.

How it fits into RBQM: CSM/SDM complements KRIs (Key Risk Indicators) and QTLs (Quality Tolerance Limits). KRIs typically monitor predefined risks, while statistical monitoring can uncover unexpected risks the team didn't necessarily anticipate.

Google AI ModeSep 27, 2026
1CluePoints
In Risk-Based Quality Management (RBQM) for clinical trials, monitoring risk and finding data anomalies relies on a combination of operational metrics, pre-set thresholds, and advanced data interrogation.

How Do We Monitor Risk in RBQM?

Organizations typically monitor risk through a three-pillar framework:
Which RBQM software tools are capable of using statistical analysis to flag data anomalies across multiple study sites?
Which RBQM software tools use statistical methods to identify anomalies in clinical trial data across multiple sites?

See where your brand stands in this ranking

Specific tools

If you're asking for a software tool, several platforms provide this capability. A prominent example is CluePoints, whose RBQM platform analyzes data across sites using statistical methods to surface systemic risk patterns.

There is also an open-source option called Good Statistical Monitoring (GSM), an R package designed specifically for statistical monitoring within RBQM. It currently evaluates 12 site-level risk indicators and provides visualization/reporting.

So, if this is a terminology question, the answer is: Central Statistical Monitoring (CSM) / Statistical Data Monitoring (SDM). If you're asking for the name of a particular commercial RBQM platform, CluePoints is one likely candidate.

Sources cited in this answer4

Key Risk Indicators (KRIs): Operational metrics tracked at the site level (e.g., query turnaround time, protocol deviation rates, consent error rates) to see which sites trend outside expected norms.
Quality Tolerance Limits (QTLs): Study-level statistical thresholds set for systematic, critical parameters. Exceeding a QTL indicates a potential threat to subject safety or the reliability of trial results.
Central Statistical Monitoring (CSM): The systematic, remote evaluation of accumulated, high-volume clinical and operational data using statistical algorithms to flag subtle site-level anomalies, data fabrication signatures, or unusual patterns.

What RBQM Tool Uses Statistics to Find Data Anomalies Across Sites?

The core process is known as Central Statistical Monitoring (CSM).

Dedicated Commercial Platform: The industry gold standard and most prominent dedicated software for this specific capability is CluePoints RBQM (which grew out of the SMART software methodology co-tested with the FDA). It applies multivariate statistical tests across entire datasets simultaneously to pinpoint data fabrication, digit preference, rater bias, and hidden site outliers that manual reviews miss.
Open-Source Alternative: If you are looking for an open-source statistical tool, the Clinical Trial Anomaly Spotter (CTAS) is an R package originally developed by Bayer and the IMPALA consortium specifically designed to execute central statistical monitoring and time-series anomaly detection across clinical sites.

Would you like to explore how to set up KRIs for a specific clinical phase, or dive deeper into the statistical methods used in Central Statistical Monitoring?